Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
- PMID: 10698352
- DOI: 10.1016/s0024-3205(99)00650-5
Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
Abstract
Resveratrol, natural compound found in grapes and wine, has been reported to have a variety of health benefit properties. Based on the structural similarity to the synthetic estrogen diethylstilbestrol, we investigated estrogenic/antiestrogenic effects on human breast cancer cell lines, MCF-7 and MVLN, and scavenging properties using DPPH of both (E)- and (Z)-isomers. Both isomers increased the in vitro growth of MCF-7 cell lines at medium concentrations (10 and 25 microM) whereas the low concentrations (0.1 and 1 microM) had no effect and the high concentration (50 microM) decreased the cell growth and was cytotoxic. The 25 microM (E)-isomer alone was able to reduced the proliferation induced by the estradiol. Low concentrations of (E)- and (Z)-resveratrol (0.1 and 1 microM) and medium concentration 10 microM (Z)-resveratrol did not interfere with the estrogen receptor. In contrast, medium concentrations of (E)-resveratrol (10 and 25 microM) and (Z)-resveratrol (25 microM) functioned as superagonists of estradiol. Whatever the model used, MCF-7 or MVLN cell lines, (Z)-resveratrol was less effective than (E)-resveratrol. Extinction of DPPH and Fe(III) reduction experiments showed that both isomers of resveratrol could act as free radicals scavengers or pro-oxidant compounds. The properties of low concentrations of resveratrol raise the possibility that structure-function studies could lead to the development of more selective estrogen receptor agonists and antagonists, which could be useful as a therapeutic agent.
Similar articles
-
Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor.Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14138-43. doi: 10.1073/pnas.94.25.14138. Proc Natl Acad Sci U S A. 1997. PMID: 9391166 Free PMC article.
-
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.Cancer Res. 2001 Oct 15;61(20):7456-63. Cancer Res. 2001. PMID: 11606380
-
Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.Cancer Res. 2001 Aug 15;61(16):6137-44. Cancer Res. 2001. PMID: 11507064
-
[Estrogenic and antiestrogenic preparations--pharmacological and clinical aspects].Akush Ginekol (Sofiia). 1985;24(4):19-22. Akush Ginekol (Sofiia). 1985. PMID: 3904498 Review. Bulgarian. No abstract available.
-
Resveratrol and resveratrol analogues--structure-activity relationship.Pharm Res. 2010 Jun;27(6):1042-8. doi: 10.1007/s11095-010-0090-1. Epub 2010 Mar 16. Pharm Res. 2010. PMID: 20232118 Review.
Cited by
-
Trans-, cis-, and dihydro-resveratrol: a comparative study.Chem Cent J. 2011 Dec 20;5:88. doi: 10.1186/1752-153X-5-88. Chem Cent J. 2011. PMID: 22185600 Free PMC article.
-
Oxidative Stress in Tauopathies: From Cause to Therapy.Antioxidants (Basel). 2022 Jul 22;11(8):1421. doi: 10.3390/antiox11081421. Antioxidants (Basel). 2022. PMID: 35892623 Free PMC article. Review.
-
Differential responses of Trans-Resveratrol on proliferation of neural progenitor cells and aged rat hippocampal neurogenesis.Sci Rep. 2016 Jun 23;6:28142. doi: 10.1038/srep28142. Sci Rep. 2016. PMID: 27334554 Free PMC article.
-
Resveratrol Inhibits Key Steps of Steroid Metabolism in a Human Estrogen-Receptor Positive Breast Cancer Model: Impact on Cellular Proliferation.Front Pharmacol. 2018 Jul 10;9:742. doi: 10.3389/fphar.2018.00742. eCollection 2018. Front Pharmacol. 2018. PMID: 30042681 Free PMC article.
-
Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.Br J Cancer. 2007 May 21;96(10):1595-604. doi: 10.1038/sj.bjc.6603755. Epub 2007 May 8. Br J Cancer. 2007. PMID: 17486135 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources